Top

Published in:

01-07-2018 | Original Paper

Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease

Authors: Samia M. Esmat, Heba H. El Hadidi, Rehab A. Hegazy, Heba I. Gawdat, Amira M. Tawdy, Marwa M. Fawzy, Dalia M. AbdelHalim, Omnia S. Sultan, Olfat G. Shaker

Published in: Archives of Dermatological Research | Issue 5/2018

Abstract

Recently, multiple culprits—in addition to melanocytes—have been implicated in the pathogenesis of vitiligo. Among those factors are fibroblasts. However, their exact role has not been clearly elucidated. The aim of the study was to evaluate the possible role played by fibroblasts in vitiligo via studying the expression Tenascin C and DKK1 in acral versus non-acral vitiligo lesions. This case–control study included 19 non-segmental vitiligo patients and ten controls. All patients were subjected to thorough clinical evaluation. Both Tenascin C and DKK1 were measured in lesional and peri-lesional skin of acral and non-acral lesions using ELISA technique. The measured levels of Tenascin C and DKK1 were significantly higher in the vitiligo group when compared to controls in all assessed sites (P < 0.05). Tenascin C was found to be significantly higher in lesional areas compared to peri-lesional ones only in the acral sites. DKK1 was significantly higher in lesional areas in all assessed sites (P < 0.05). The current work suggests a malfunction of fibroblasts in vitiligo, through demonstrating significant up-regulation of two melanogenesis inhibitory products (Tenascin C and DKK1) in patients compared to controls. Larger scale studies are warranted to detect the possible implications of such findings on vitiligo treatment.

Abdou AG, Maraee AH, Shoeib MA, Elbana R (2012) Immunolocalization of tenascin-C in vitiligo. Appl Immunohistochem Mol Morphol 20(5):501–511CrossRefPubMed

Begum R, Marfatia YS, Laddha NC, Dwivedi M, Singh M (2014)) Vitiligo: a complex disease and a complex approach. Mol Cytogen 7:1–157CrossRef

Buffey JA, Messenger AG, Taylor M, Ashcroft AT, Westgate GE, MacNeil S (1994) Extracellular matrix derived from hair and skin fibroblasts stimulates human skin melanocyte tyrosinase activity. Br J Dermatol 131(6):836–842CrossRefPubMed

Cario-André M, Pain C, Gauthier Y, Casoli V, Taieb A (2006) In vivo and in vitro evidence of dermal fibroblasts influence on human epidermal pigmentation. Pigment Cell Res 19(5):434–442CrossRefPubMed

Chiquet-Ehrismann R, Kalla P, Pearson CA et al (1988) Tenascin interferes with fibronectin action. Cell 53:383–390CrossRefPubMed

Duval C, Cohen C, Chagnoleau C, Flouret V, Bourreau E, Bernerd F (2014) Key regulatory role of dermal fibroblasts in pigmentation as demonstrated using a reconstructed skin model: impact of photo-aging. PLoS One 9:e114182CrossRefPubMedPubMedCentral

Esmat SM, El-Tawdy AM, Hafez GA, Zeid OA, Abdel Halim DM, Saleh MA, Leheta TM, Elmofty M (2012) Acral lesions of vitiligo: why are they resistant to photochemotherapy? J Eur Acad Dermatol Venereol 26(9):1097–1104CrossRefPubMed

Gauthier Y, Cario Andre M, Taïeb A (2003) A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res 16(4):322–332CrossRefPubMed

Gulcher JR, Nies DE, Alexakos MJ, Ravikant NA, Sturgill ME, Marton LS, Stefansson K (1991) Structure of the human hexabrachion (tenascin) gene. Proc Natl Acad Sci USA 88(21):9438–9442CrossRefPubMedPubMedCentral

10.

Hautmann G, Moretti S, Lotti T, Hercogova` J (2004) Pathogenesis of vitiligo: evidence for a possible ongoing disorder of the cutaneous microenvironment. In: Lotti T, Hercogova` J (eds) Vitiligo: new data and hypotheses. Marcel-Dekker, New York, pp 99–121

11.

Hegazy RA, Fawzy MM, Gawdat HI, Samir N, Rashed LA (2014) T helper 17 and Tregs: a novel proposed mechanism for NB-UVB in vitiligo. Exp Dermatol 23(4):283–286CrossRefPubMed

12.

Imokawa G (2004) Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res 17(2):96–110CrossRefPubMed

13.

Kim YC, Kim YJ, Kang HY et al (2008) Histopathologic features invitiligo. Am J Dermatopathol 30:112–116CrossRefPubMed

14.

Kumar R, Parsad D, Kanwar AJ, Kaul D (2011) Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Br J Dermatol 165(2):285–291CrossRefPubMed

15.

Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK (1997) Tenascin is overexpressed in vitiligo lesional skin and inhibits melanocyte adhesion. Br J Dermatol 137(2):171–178CrossRefPubMed

16.

Marionnet C, Pierrard C, Vioux-Chagnoleau C, Sok J, Asselineau D, Bernerd F (2006) Interactions between fibroblasts and keratinocytes in morphogenesis of dermal- epidermal junction in a model of reconstructed skin. J Invest Dermatol 126:971–979CrossRefPubMed

17.

Midwood K, Sacre S, Piccinini AM et al (2009)) Tenascin-C is an endogenous activator of toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 15:774–780CrossRefPubMed

18.

Midwood K, Orend G (2009) The role of tenascin-C in tissue injury and tumorigenesis. J Cell Commun Signal 3(3–4):287–310CrossRefPubMedPubMedCentral

19.

Moretti S, Fabbri P, Baroni G, Berti S, Bani D, Berti E, Nassini R, Lotti T, Massi D (2009) Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis. Histol Histopathol 24(7):849–857PubMed

20.

Oh SH, Kim JY, Kim MR, Do JE, Shin JY, Hann SK (2012) DKK1 is highly expressed in the dermis of vitiligo lesion: is there association between DKK1 and vitiligo? J Dermatol Sci 66(2):163–165CrossRefPubMed

21.

Pesheva P, Probstmeier R, Skubitz AP, McCarthy JB, Furcht LT, Schachner M (1994) Tenascin-R (J1 160/180 inhibits fibronectin-mediated cell adhesion–functional relatedness to tenascin-C. J Cell Sci 107:2323–2333PubMed

22.

Schirmer C, Klein C, von Bergen M, Simon JC, Saalbach A (2010) Human fibroblasts support the expansion of IL-17-producing T cells via up-regulation of IL-23 production by dendritic cells. Blood 116(10):1715–1725CrossRefPubMed

23.

Taïeb A, Morice-Picard F, Jouary T, Ezzedine K, Cario-André M, Gauthier Y (2008) Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res 21(6):646–652CrossRefPubMed

24.

Yamaguchi Y, Morita A, Maeda A, Hearing VJ (2009) Regulation of skin pigmentation and thickness by Dickkopf 1 (DKK1). J Investig Dermatol Symp Proc 14(1):73–75CrossRefPubMedPubMedCentral

25.

Yamaguchi Y, Passeron T, Hoashi T, Watabe H, Rouzaud F, Yasumoto K, Hara T, Tohyama C, Katayama I, Miki T, Hearing VJ (2008) Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/beta-catenin signaling in keratinocytes. FASEB J 22(4):1009–1020CrossRefPubMed

Title: Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease
Authors: Samia M. Esmat
Heba H. El Hadidi
Rehab A. Hegazy
Heba I. Gawdat
Amira M. Tawdy
Marwa M. Fawzy
Dalia M. AbdelHalim
Omnia S. Sultan
Olfat G. Shaker
Publication date: 01-07-2018
Publisher: Springer Berlin Heidelberg
Published in: Archives of Dermatological Research / Issue 5/2018
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-018-1830-z

At a glance: The STEP trials

Springer Medicine

Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2018

Dermal white adipose tissue undergoes major morphological changes during the spontaneous and induced murine hair follicle cycling: a reappraisal

UVA-photoprotective potential of silymarin and silybin

Expression of IL33 and IL35 in oral lichen planus

Androgen modulation of Wnt/β-catenin signaling in androgenetic alopecia

Ex vivo nonlinear microscopy imaging of Ehlers–Danlos syndrome-affected skin

Anthocyanins from black soybean seed coat prevent radiation-induced skin fibrosis by downregulating TGF-β and Smad3 expression